ConductScience.org, home
Papers
API referenceFor AI assistants

Paper · 36884136

In vivo detection of circulating tumor cells predicts high-risk features in patients with bladder cancer.

Jin D and 9 others. Med Oncol, 2023. Cited by 3 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. In vivo detection of circulating tumor cells predicts high-risk features in patients with bladder cancer. Papers, record 36884136. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36884136

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
In vivo detection of circulating tumor cells predicts high-risk features in patients with bladder cancer.
PubMed
Journal
Med Oncol
PubMed
Year
2023
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
3
iCite
Relative citation ratio, by iCite
0.23
iCite
Revised in PubMed
2026-10-30
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Jin DDi
2Qian LLei
3Xia JJun
4Zhang RRuiyun
5Yang GGuoliang
6Zhang LLianhua
7Xue WWei
8Cao MMing
9Dong LLiang
10Chen HHaigehttps://orcid.org/0000-0002-1846-8141

Source PubMed

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Carcinoma, Non-Small-Cell LungMajor topic
Lung NeoplasmsMajor topic
Neoplastic Cells, CirculatingMajor topic
Urinary Bladder NeoplasmsMajor topic
Humans
B7-H1 Antigen
Biomarkers, Tumor

Source PubMed

Grants5

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
82173076National Natural Science Foundation of ChinaPubMed
82103485National Natural Science Foundation of ChinaPubMed
20Y11904900Natural Science Foundation of ShanghaiPubMed
2022YQ014Shanghai Municipal Health CommissionPubMed
SHDC2022CRD034Shanghai Hospital Development CenterPubMed

Source PubMed

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References41

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132,059,957Liquid Biopsies to Select Patients for Perioperative Chemotherapy in Muscle-invasive Bladder Cancer: A Systematic Review.Eur Urol Oncol2021https://conductscience.org/library/papers/32059957PubMed
223,781,285Detecting circulating tumor cells: current challenges and new trends.Theranostics2013https://conductscience.org/library/papers/23781285PubMed
320,005,748The presence of circulating tumor cells does not predict extravesical disease in bladder cancer patients prior to radical cystectomy.Urol Oncol2012https://conductscience.org/library/papers/20005748PubMed
435,020,204Cancer statistics, 2022.CA Cancer J Clin2022https://conductscience.org/library/papers/35020204PubMed
529,947,424Basal-subtype bladder tumours show a 'hot' immunophenotype.Histopathology2018https://conductscience.org/library/papers/29947424PubMed
632,017,145Detection of Circulating Tumor Cells and Their Implications as a Biomarker for Diagnosis, Prognostication, and Therapeutic Monitoring in Hepatocellular Carcinoma.Hepatology2021https://conductscience.org/library/papers/32017145PubMed
728,988,769Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer.Cell2017https://conductscience.org/library/papers/28988769PubMed
834,242,363Prognostic value of circulating tumor cells in patients with bladder cancer: A meta-analysis.PLoS One2021https://conductscience.org/library/papers/34242363PubMed
931,185,699Analysis of Circulating Tumor Cells in Patients with Non-Metastatic High-Risk Prostate Cancer before and after Radiotherapy Using Three Different Enumeration Assays.Cancers (Basel)2019https://conductscience.org/library/papers/31185699PubMed
1015,967,252Cystectomy in patients with high risk superficial bladder tumors who fail intravesical BCG therapy: pre-cystectomy prostate involvement as a prognostic factor.Eur Urol2005https://conductscience.org/library/papers/15967252PubMed

1 to 10 of 41

See all 41 references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

PMIDTitleJournalYearIn PapersSource
42,870,280Liquid biopsy in bladder cancer: towards precision oncology.J Transl Med2026https://conductscience.org/library/papers/42870280PubMed
42,351,435PD-L1+ CTCs Are Associated with Adverse Pathological Features and Unfavorable Prognosis in Bladder Cancer.Diagnostics (Basel)2026https://conductscience.org/library/papers/42351435PubMed
40,234,713Circulating tumour DNA and circulating tumour cells in bladder cancer - from discovery to clinical implementation.Nat Rev Urol2025https://conductscience.org/library/papers/40234713PubMed
40,027,303A revolutionary era in advancing precision immuno-oncology; role of circulating tumor cells.J Liq Biopsy2024https://conductscience.org/library/papers/40027303PubMed

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
CD27429,126PubTator's text mininghttps://conductscience.org/library/genes/29126

Source NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36884136

GET https://conductscience.org/api/papers/v1/36884136/references?page=2

API referenceFor AI assistants